Alterations in the cortical serotonergic system in schizophrenia: A postmortem study

Biological Psychiatry

Volumn 42, Issue 7, 1997, Pages 529-545

  Gurevich, E V ^a   Joyce, J N ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Antipsychotics; Prefrontal cortex; Schizophrenia; Serotonin uptake sites; Serotonin(1A) receptor; Serotonin2 receptor

Indexed keywords

NEUROLEPTIC AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECEPTOR DENSITY; SCHIZOPHRENIA; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM;

EID: 0030825125     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00321-1     Document Type: Article

References (54)

1. 3H]paroxetine binding Gerontology 38 1992 127 132
2. Andreasen NC Rezai K Alliger R Swayze VW Jr Flaum M Kirchner P Hypofrontality in neuroleptic-naive patients and patients with chronic schizophrenia Assessment with xenon 133 single-photon emission computed tomography and the Tower of London Arch Gen Psychiatry 49 1992 943 958
3. Andree TH Mikuni M Tong CY Koenig JI Meltzer HY Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex J Neurochem 46 1986 191 197
4. Arango V Underwood MD Gubbi AV Mann JJ Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims Brain Res 688 1995 121 133
5. Arnold SE Gur RE Shapiro RM Fisher KR Moberg PJ Gibney MR Prospective clinicopathological studies of schizophrenia: Accrual and assessment Am J Psychiatry 152 1995 731 737
6. 2 binding sites in the frontal cortex of suicide victims and control subjects Am J Psychiatry 146 1989 730 736
7. 2) receptor binding in the frontal cortex of schizophrenic patients J Neural Transm 85 1991 19 29
8. Biver F Goldman S Luxen A Delvenne V De Maertelaer V De La Fuente J Altered frontostriatal relationship in unmedicated schizophrenic patients Psychiatry Res 61 1995 161 171
9. 1251]RTI-55 to dopamine and serotonin transporters in rat brain Synapse 12 1992 27 36
10. Braak H Architectonics of the Human Telencephalic Cortex 1980 Springer-Verlag Berlin
11. 2A receptor mRNA in human brain Brain Res 676 1995 157 168
12. 2A receptor mRNAs and binding sites densities are differentially altered in schizophrenia Neuropsychopharmacology 15 1996 442 455
13. Carlsson A The current status of the dopamine hypothesis of schizophrenia Neuropsychopharmacology 1 1988 11 22
14. 3H]Paroxetine binding is altered in the hippocampus but not in the frontal cortex or caudate nucleus from subjects with schizophrenia J Neurochem 64 1995 1197 1202
15. 2 receptors and the serotonin transporter in the schizophrenic brain Behav Brain Res 73 1996 169 175
16. 2 receptor antagonist, ritanserin, on biogenic amines in ther rat nucleus accumben Eur J Pharmacol 192 1991 427 429
17. Ebmeier KP Lawrie SM Blackwood DH Johnstone EC Goodwin GM Hypofrontality revisited: A high resolution single photon emission computed tomography study in schizophrenia J Neurol Neurosurg Psychiatry 58 1995 452 456
18. Geres M Tello A Selected quantitative EEG (QEEG) and event-related potential (ERP) variables as discriminators for positive and negative schizophrenia Biol Psychiatry 38 1995 34 49
19. Goldsmith SK Shapiro RM Joyce JN Dopamine D2 receptor distribution in temporal lobe is disrupted in schizophrenia Arch Gen Psychiatry 54 1997 649 658
20. 3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain Neuropsychopharmacology 14 1996 309 323
21. Gurevich EV Bordelon Y Shapiro RM Arnold SE Gur RE Joyce JN Mesolimbic dopamine D3 receptors and use of antipsychotics in schizophrenic patients A postmortem study Arch Gen Psychiatry 54 1997 225 232
22. 2, receptor binding in patients with chronic schizophrenia Psychopharmacology 112 Suppl 1 1993 S35 S39
23. 2 sites in cortex and amygdala Brain Res 614 1993 37 44
24. Joyce JN Shane A Lexow N Winokur A Casanova MF Kleinman JE Serotonin uptake sites and serotonin receptors are altered in the limbic systemof schizophrenics Neuropsychopharmacology 8 1993 315 336
25. Joyce JN, Goldsmith SK, Gurevich EV (in press): Limbic circuits and monoamine receptors: Dissecting the effects of antipsychotics from disease processes. J Psychiat Res.
26. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs Neuropsychopharmacology 13 1995 139 150
27. Laruelle M Abi-Dargham A Casanova M Toti R Weinberger DR Kleinman JE Selective abnormalities of prefrontal serotonergic receptors in schizophrenia Arch Gen Psychiatry 50 1993 810 818
28. Leysen JE Janssen PM Gommeren W Wynants J Pauwels PJ Janssen PA In Vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone Mol Pharmacol 41 1992 494 508
29. 2 receptor modulation on DOPAC and 5-HIAA level in rat striatum and nucleus accumbens: Microdialysis studies of freely moving rats Prog Neuropsychopharmacol Biol Psychiatry 20 1996 307 322
30. Maher BA Manschreck TC Woods BT Yurgelun-Todd DA Tsuang MT Frontal brain volume and context effect in short-term recall in schizophrenia Biol Psychiatry 37 1995 144 150
31. Matsubara S Meltzer HY Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex Life Sci 45 1989 1397 1406
32. Meltzer HY Matsubara S Lee JC Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2, and serotonin2 pKi values J Pharmacol Exp Ther 251 1989 238 246
33. Mita T Hanada S Nishino N Kuno T Nakai H Yamadori T Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics Biol Psychiatry 21 1986 1407 1414
34. 2) receptor mediated enhancement of cortical unit activity Can J Physiol 70 1992 1604 1609
35. O'Dell SJ La Hoste GJ Widmark CB Shapiro RM Potkin SG Marshall JF Chronic treatment with clozapine or haloperidol differentially regulate dopamine and serotonin receptors in rat brain Synapse 6 1990 146 153
36. 2 and D2 antagonist, on dopamine and 5-HT receptors in rats Prog Neuropsychopharmacol Biol Psychiatry 19 1995 1091 1101
37. Ohuoha DC Hyde TM Kleinmau JE The role of serotonin in schizophrenia: An overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system Psychopharmacology 112 suppl 1 1993 S5 S15
38. Pantelis C Brewer W Neuropsychological and olfactory dysfunction in schizophrenia: Relationship of frontal syndromes to syndromes of schizophrenia Schizophr Res 17 1995 35 45
39. Pearlson GD Petty RG Ross CA Tien AY Schizophrenia: A diseaseof heteromodaf association cortex? Neuropsychopharmacology 14 1996 1 17
40. Peroutka SJ Snyder SS Relationship of neuroleptic drugs effects at brain dopamine, serotonin, a-adrenergic and histamine receptors to clinical potency Am J Psychiatry 137 1980 1518 1522
41. Preuss TM Goldman-Rakic PS Myelo- and cytoarchitecture of the granular frontal cortex and surrounding regions in the Strepsirhine primate Galago and the anthropoid primate Macaca J Comp Neurol 310 1991 429 474
42. Rajkowska G Goldman-Rakic PS Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria Cereb Cortex 5 1995 307 322
43. Ross CA Pearlson GD Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach Trends Neurosci 19 1996 171 176
44. Schröder J Buchsbaum MS Siegel BV Geider FJ Lohr J Tang C Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia Schizophr Res. 19 1996 41 53
45. Seidman U Yugelun-Todd D Kremen WS Woods BT Goldstein JM Faraone SV Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia Biol Psychiatry 35 1994 235 246
46. Shapiro LA Offord SJ Ordway GA The effect of chronic treatment with a novel aryl piperazine antipsychotic on monoamine receptors in rat brain Brain Res 677 1995 250 256
47. Siegel BV Jr Buchsbaum MS Bunney WE Jr Gottschalk LA Haier RJ Lohr JB Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients Am J Psychiatry 150 1993 1325 1326
48. 1A receptors in ventral prefrontal cortex in schizophrenia Biol Psychiatry 39 1996 919 928
49. 2 receptor subtypes J Psychiatry Neurosci 21 1996 29 35
50. Stanley JA Williamson PC Drost DJ Carr TJ Rylett RJ Malla A An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy Arch Gen Psychiatry 52 1995 399 406
51. 1A receptors are increased in post-mortem prefrontal cortex in schizophrenia Brain Res 708 1996 209 214
52. Watanabe-Sawaguchi K Kubota K Arikuni T Cytoarchitecture and intrafrontal connections of the frontal cortex of the brain of the hamadryas baboon (Papio hamadryas) J Comp Neurol 311 1991 108 133
53. 2) and dopamine (D2) receptors in the rat brain Brain Res 487 1989 288 298
54. Wolkin A Sanfilipo M Wolf AP Angrist B Brodie JD Rotrosen J Negative symptoms and hypofrontality in chronic schizophrenia Arch Gen Psychiatry 49 1992 959 965